ethyl chloroformate has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikemoto, S; Maekawa, M; Mori, K; Nishio, S | 1 |
| Lamm, DL; Pickett, SH; Rochester, MG; Sarosdy, MF; Stogdill, BJ | 1 |
2 other study(ies) available for ethyl chloroformate and Bladder Cancer
| Article | Year |
|---|---|
Ethylchlorformate polymerized tumor protein immunotherapy of the murine bladder tumor.
Topics: Animals; BCG Vaccine; Carcinoma, Transitional Cell; Formates; Formic Acid Esters; Immunotherapy; Mice; Mice, Inbred C3H; Neoplasm Proteins; Polymers; Urinary Bladder Neoplasms | 1989 |
Tumor-specific immunotherapy of murine bladder cancer with butanol-extracted antigens and ethylchlorformate polymerized tumor protein.
Topics: Animals; Antigens, Neoplasm; BCG Vaccine; Butanols; Carcinoma, Transitional Cell; Formates; Formic Acid Esters; Mice; Mice, Inbred C3H; Neoplasm Proteins; Polymers; Urinary Bladder Neoplasms | 1988 |